Abstracts Archive - Page 270 of 1683 - ATC Abstracts

2021 American Transplant Congress
Donor-specific Anti-HLA Alloantibody in Kidney Transplant Recipients with COVID-19 Exhibit a Different Immunoglobulin Class and Subclass Profile When Compared to Anti-SARS-CoV-2 Antibodies
A. Girnita¹, L. Wang¹, M. Fernandez-Vina¹, E. Woodle², P. Ahearn¹, T. Yalamarti¹, M. Menon³, Y. Azzi⁴, M. Melcher¹, R. Bray⁵, H. Gebel⁵, E. Akalin⁴, P. Cravedi³, J. S. Maltzman¹
¹Stanford University, Palo Alto, CA, ²University of Cincinnati, Cincinnati, OH, ³Icahn School of Medicine, NYC, NY, ⁴Einstein School of Medicine, NYC, NY, ⁵Emory University, Atlanta, GA
*Purpose: Both anti-HLA and anti-SARS-CoV-2 antibodies target protein antigens. The aim of the present study was to compare the class and subclass profile of such…
2021 American Transplant Congress
Covid-19 Severity within One Year of Liver, Pancreas and Kidney Transplantation
H. Sarumi, J. Fisher, B. Johnson, T. Pruett
Solid Organ Transplant Surgery, University of Minnesota, Minneapolis, MN
*Purpose: The current pandemic has created uncertainty in the severity of COVID-19 in transplant recipients, especially those given lymphocyte depleting therapy within a year prior…
2021 American Transplant Congress
Creating a Lung Transplant Program Search Tool Tailored to Patient Characteristics
W. T. McKinney¹, C. R. Schaffhausen¹, M. Bruin², S. Chu², J. Snyder³, M. Hertz⁴, M. Valapour⁵, B. Kasiske⁶, A. Israni¹
¹Hennepin Healthcare Research Institute, Minneapolis, MN, ²College of Design, University of Minnesota, Minneapolis, MN, ³Scientific Registry of Transplant Recipients, Minneapolis, MN, ⁴Medical School, University of Minnesota, Minneapolis, MN, ⁵Pulmonary Medicine, Cleveland Clinic, Cleveland, OH, ⁶Nephrology, Hennepin Healthcare, Minneapolis, MN
*Purpose: Criteria for selecting lung transplant candidates and donors vary between programs and evolve as clinical practice advances. This variation impacts patient outcomes and the…
2021 American Transplant Congress
Outcomes of Covid 19 in Candidates Waitlisted for Kidney and Pancreas Transplantation
R. El-Rifai¹, S. Riad¹, R. Belina², A. Matas²
¹Medicine, University of Minnesota, Minneapolis, MN, ²Surgery, University of Minnesota, Minneapolis, MN
*Purpose: The COVID 19 pandemic has posed new challenges to transplant centers. The impact has been detrimental on wait-listed ESKD patients, reducing their access to…
2021 American Transplant Congress
A Retrospective Analysis of the Safety and Efficacy of Apixaban After Lung Transplant
T. Sam¹, K. Reininger², R. Patel¹, C. Naik¹, K. Ausloos¹, R. Rosenblatt¹, T. Grazia¹, I. Lam³
¹Transplant, Baylor University Medical Center, Dallas, TX, ²Transplant, Hennepin County Medical Center, Minneapolis, MN, ³Transplant, Sharp Memorial Hospital, San Diego, CA
*Purpose: Atrial arrhythmias and venous thromboembolism (VTE) are common after lung transplant. While direct acting oral anticoagulants (DOACs) have become anticoagulants of choice in atrial…
2021 American Transplant Congress
Impact of a “COVID-free” Pathway on Living Donor Transplantation During a Pandemic
S. Koganti, Y. Cheah, C. J. Simon, M. Tobon Lascano, J. Kim, M. E. Akoad
Lahey Hospital & Medical Center, Burlington, MA
*Purpose: COVID-19 pandemic has significantly decreased rates of organ transplantation, with most programs curtailing living donor transplantations. This has led to an increase in waitlist…
2021 American Transplant Congress
Mortality from Fulminant Myocarditis in Multi-organ Transplant Recipient with Covid-19
K. Mahendraraj, I. Kim, T. Todo, T. Brennan, N. Nissen, K. Kosari, G. Voidonikolas, D. Ramzy
Transplant Surgery, Cedars-Sinai Medical Center, Los Angeles, CA
*Purpose: Novel coronavirus infection has been rarely described in multi-organ transplantation. This case highlights the poor prognosis associated with cardiac involvement by SARS-Cov-2 in transplantation,…
2021 American Transplant Congress
Cancer-Specific Mortality in Solid Organ Transplant Recipients with a Prior Cancer Diagnosis
E. Engels¹, G. Haber¹, A. Hart², C. Lynch³, J. Li⁴, K. Pawlish⁴, B. Qiao⁵, K. Yu¹, R. Pfeiffer¹
¹Natl Cancer Inst, Bethesda, MD, ²Univ of Minnesota, Minneapolis, MN, ³Univ of Iowa, Iowa City, IA, ⁴New Jersey Dept of Health, Trenton, NJ, ⁵New York State Dept of Health, Albany, NY
*Purpose: A history of cancer is increasingly common among solid organ transplant candidates, and transplant-associated immunosuppression may increase recurrence risk. We assessed whether transplantation was…
2021 American Transplant Congress
Living Organ Donor Perspectives on Covid-19 Vaccines
M. N. Harhay¹, A. Klassen², H. Zaidi¹, M. Mittelman³, R. Bertha³, R. Mannon⁴, K. Lentine⁵
¹Medicine, Drexel University, Philadelphia, PA, ²Drexel University, Philadelphia, PA, ³American Living Organ Donor Fund, Philadelphia, PA, ⁴University of Nebraska Medical Center, Omaha, NE, ⁵Saint Louis University, Saint Louis, MO
*Purpose: Promoting widespread COVID-19 vaccinations is a crucial strategy to protect living organ donors and transplant recipients during the pandemic. We examined perspectives and sources…
2021 American Transplant Congress
Black Transplant Recipients Reside in the Most Socially Vulnerable Communities
A. C. Killian¹, M. C. McLeod¹, B. Shelton¹, R. D. Reed¹, P. MacLennan¹, H. Qu¹, B. J. Orandi¹, D. Sawinski², J. E. Locke¹
¹University of Alabama at Birmingham Hospital, Birmingham, AL, ²Hospital of the University of Pennsylvania, Philadelphia, PA
*Purpose: Racial and socioeconomic disparities in post-transplant outcomes have been described for all solid organ recipients. While the importance of the social determinants of health…